Exp Mol Med.  2010 Dec;42(12):823-832. 10.3858/emm.2010.42.12.085.

Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra

Affiliations
  • 1Neuroscience Graduate Program, Ajou University School of Medicine, Suwon 442-721, Korea. ehjoe@ajou.ac.kr
  • 2Department of Pharmacology, Ajou University School of Medicine, Suwon 442-721, Korea.
  • 3Chronic Inflammatory Disease Research Center, Ajou University School of Medicine, Suwon 442-721, Korea.
  • 4Brain Disease Research Center, Ajou University School of Medicine, Suwon 442-721, Korea.

Abstract

It has been suggested that brain inflammation is important in aggravation of brain damage and/or that inflammation causes neurodegenerative diseases including Parkinson's disease (PD). Recently, systemic inflammation has also emerged as a risk factor for PD. In the present study, we evaluated how systemic inflammation induced by intravenous (iv) lipopolysaccharides (LPS) injection affected brain inflammation and neuronal damage in the rat. Interestingly, almost all brain inflammatory responses, including morphological activation of microglia, neutrophil infiltration, and mRNA/protein expression of inflammatory mediators, appeared within 4-8 h, and subsided within 1-3 days, in the substantia nigra (SN), where dopaminergic neurons are located. More importantly, however, dopaminergic neuronal loss was not detectable for up to 8 d after iv LPS injection. Together, these results indicate that acute induction of systemic inflammation causes brain inflammation, but this is not sufficiently toxic to induce neuronal injury.

Keyword

brain inflammation; neuronal damage; systemic inflammation

MeSH Terms

Animals
Astrocytes/pathology
Cell Death
Encephalitis/chemically induced/immunology/*pathology
Injections, Intravenous
Lipopolysaccharides/*pharmacology
Male
Microglia/pathology
Neutrophil Infiltration
Rats
Rats, Sprague-Dawley
Substantia Nigra/immunology/*pathology
Full Text Links
  • EMM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr